NICE approves extra ‘triple therapy’ drug for diabetes

Regulator recommends dapagliflozin in triple therapy Related items from OnMedica Glycosylated haemoglobin (HbA1c) and screening for diabetes Diabetes drugs costs NHS England nearly £1bn a year Intensive treatment of type 2 diabetes with microalbuminuria reaps benefits NICE guidance delays hinder good diabetes care Diabetes prescriptions rise by a third in last five years

via OnMedica News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/2fIWVAU